The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Zytiga Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused update on Zytiga availability in 2026. Covers supply status, prescribing considerations, cost barriers, and tools to help patients.

Nayzilam Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on the 2026 Nayzilam shortage: supply chain analysis, therapeutic alternatives, prescribing strategies, and patient resources.
Ethosuximide Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Ethosuximide availability in 2026. Shortage timeline, prescribing implications, alternatives, and tools to help your patients.

Ethyl Chloride Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on Ethyl Chloride availability in 2026: supply status, prescribing implications, alternatives, and tools.
48,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Augmentin Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on the 2026 Augmentin shortage: timeline, prescribing implications, availability by formulation, cost impacts, and clinical alternatives.

Omnitrope Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused 2026 briefing on Omnitrope availability, the somatropin market, prior authorization challenges, and clinical guidance for managing patient access.

How to Help Your Patients Save Money on Doxepin: A Provider's Guide to Savings Programs
A clinical guide for providers on all available doxepin savings programs, copay assistance, patient assistance, and cost-reduction strategies to help patients afford their medication.

How to Help Your Patients Save Money on Olumiant: A Provider's Guide to Savings Programs
A provider's guide to helping patients access savings programs for Olumiant (baricitinib), including the Olumiant Together card, Lilly Cares, and Medicare options.

How to Help Your Patients Save Money on Skyrizi: A Provider's Guide to Savings Programs
Skyrizi costs ~$22,000 per dose without assistance. This provider guide covers every savings program available to help your patients afford Skyrizi in 2026—from co-pay cards to PAPs.

How to Help Your Patients Save Money on Exparel: A Provider's Guide to Savings Programs
Exparel costs $444+ per vial and coverage varies widely. Here's a complete provider guide to PaciraConnect, the NOPAIN Act, prior auth, and patient assistance options.

Bimatoprost Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Bimatoprost availability in 2026. Shortage timeline, prescribing implications, cost and access challenges, and tools to help patients.

Buspar Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Buspar (Buspirone) availability in 2026: shortage timeline, prescribing implications, cost/access landscape, and tools to help your patients.